These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3029793)

  • 21. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
    Sircar R; Nichtenhauser R; Ieni JR; Zukin SR
    J Pharmacol Exp Ther; 1986 May; 237(2):681-8. PubMed ID: 3009795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs.
    Glennon RA; Young R; Herndon JL
    Pharmacol Biochem Behav; 1993 Aug; 45(4):865-9. PubMed ID: 8105490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor mediation of the discriminative stimulus properties of phencyclidine and sigma-opioid agonists.
    Balster RL; Willetts J
    Psychopharmacol Ser; 1988; 4():122-35. PubMed ID: 2899317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
    Singh L; Wong EH; Kesingland AC; Tricklebank MD
    Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic and reinforcing properties of phencyclidine and the enantiomers of N-allylnormetazocine in the dog.
    Vaupel DB; Risner ME; Shannon HE
    Drug Alcohol Depend; 1986 Oct; 18(2):173-94. PubMed ID: 3780414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotomimetic sigma-ligands, dexoxadrol and phencyclidine block the same presynaptic potassium channel in rat brain.
    Bartschat DK; Blaustein MP
    J Physiol; 1988 Sep; 403():341-53. PubMed ID: 3253423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.
    White JM; Holtzman SG
    Psychopharmacology (Berl); 1983; 80(1):1-9. PubMed ID: 6408661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey.
    Holtzman SG
    Psychopharmacology (Berl); 1982; 77(4):295-300. PubMed ID: 6813889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys.
    Katz JL; Spealman RD; Clark RD
    J Pharmacol Exp Ther; 1985 Feb; 232(2):452-61. PubMed ID: 3968644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity of the enantiomers of alpha- and beta-cyclazocine for binding to the phencyclidine and mu opioid receptors.
    Todd SL; Balster RL; Martin BR
    Life Sci; 1990; 46(12):895-901. PubMed ID: 2157122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of [3H]phencyclidine and (+)-[3H]SKF-10,047 binding sites in rat cerebral cortex.
    Goldman ME; Jacobson AE; Rice KC; Paul SM
    FEBS Lett; 1985 Oct; 190(2):333-6. PubMed ID: 2995139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites.
    Itzhak Y
    Life Sci; 1988; 42(7):745-52. PubMed ID: 2893238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of sigma and PCP-like drugs on operant behaviors in the rat.
    Hudzik TJ; Slifer BL
    Psychopharmacology (Berl); 1992; 108(1-2):115-22. PubMed ID: 1410131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.
    Slifer BL; Balster RL
    J Pharmacol Exp Ther; 1983 Jun; 225(3):522-8. PubMed ID: 6306209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
    Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding.
    Johnson KM; Snell LD
    Pharmacol Biochem Behav; 1985 May; 22(5):731-5. PubMed ID: 2989942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]PCP-3-OH and (+)[3H]SKF 10047 binding sites in rat brain membranes: evidence of multiplicity.
    Itzhak Y
    Eur J Pharmacol; 1987 Apr; 136(2):231-4. PubMed ID: 3036548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of arylcyclohexylamines as discriminative stimuli in pigeons.
    McMillan DE; Evans EB; Wessinger WD; Owens SM
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1086-92. PubMed ID: 2849658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.